Expected catalystAugust 31, 2026Company guidance: Aug 31, 2026
Catalyst overview
Event details
- Drug or asset
- RP-1664
- Development stage
- Phase 1
- Event type
- Data readout
- Indication
- Cancer, Solid tumor/s
Research summary
What is being tracked?
This catalyst tracks a Phase 1 data readout for RP-1664 in Cancer, Solid tumor/s. The expected timing is based on the latest available company guidance and may change.
Development notes
LIONS trial. 2/15/24- Dosed first patient. 3/3/25- Final data readout of PoC in Mid-2026. 10/25/25– Presented initial data at AACR-NCI-EORTC’25.
Verification
Primary source
Confirm timing and program details against the company announcement or filing.